MARKET

CAH

CAH

Cardinal Health Inc
NYSE

Real-time Quotes | Nasdaq Last Sale

55.80
-0.03
-0.05%
After Hours: 55.90 +0.1 +0.18% 16:53 05/20 EDT
OPEN
55.87
PREV CLOSE
55.83
HIGH
56.16
LOW
54.67
VOLUME
2.26M
TURNOVER
--
52 WEEK HIGH
64.53
52 WEEK LOW
45.03
MARKET CAP
15.20B
P/E (TTM)
-15.7117
1D
5D
1M
3M
1Y
5Y
Healthcare Stock to Target as the Broader Market Plummets
A historically bullish signal is flashing for the equity as well
Schaeffer's Investment Research · 2d ago
Cardinal Health upgraded to outperform at Evercore as market ignoring medical business
Evercore had upgraded Cardinal Health (NYSE:CAH) to outperform from in line saying that the market is not valuing the healthcare products distributor's medical segment. The firm boosted its price target
Seekingalpha · 2d ago
Evercore ISI Upgrades Cardinal Health to Outperform From In-Line, Adjusts Price Target to $68 From $55
MT Newswires · 3d ago
Cardinal Health secures $2.25B defense modification contract
Cardinal Health (NYSE:CAH) has been awarded a maximum $2.25B modification (P00046) exercising the second 30-month option period of a 30-month base contract (SPE2DV-17-D0001) with three 30-month option periods for worldwide ordering
Seekingalpha · 05/11 21:14
Cardinal Health raises dividend by 1% to $0.4957/share
Cardinal Health (NYSE:CAH) declares $0.4957/share quarterly dividend, 1% increase from prior dividend of $0.4908. Forward yield 3.54% Payable July 15; for shareholders of record July 1; ex-div June 30. See
Seekingalpha · 05/10 20:24
--Credit Suisse Lowers Cardinal Health's PT to $56 from $58, Notes Guidance Cut Due to Inflationary Impacts, Keeps Neutral Rating
MT Newswires · 05/06 10:42
Cardinal Health has no plans to divest struggling medical supply business, CEO Mike Kaufmann says
Cardinal Health has no plans to sell its medical supply division despite ongoing struggles, this time due to inflation, CEO Mike Kaufmann said.
American City Business Journals · 05/05 18:43
Cardinal Health's Shares Fall as Inflation and Supply Chain Constraints Hit Q3 Earnings
Benzinga · 05/05 15:54
More
No Data
Learn about the latest financial forecast of CAH. Analyze the recent business situations of Cardinal Health Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 16 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
31.25%Buy
62.50%Hold
6.25%Under-perform
0.00%Sell
Analyst Price Target
The average CAH stock price target is 60.77 with a high estimate of 74.00 and a low estimate of 51.00.
High74.00
Average60.77
Low51.00
Current 55.80
EPS
Actual
Estimate
0.380.771.151.53
Q4 2021
Q1 2022
Q2 2022
Q3 2022
Q4 2022
Institutional Holdings
Institutions: 1.12K
Institutional Holdings: 260.77M
% Owned: 95.72%
Shares Outstanding: 272.43M
TypeInstitutionsShares
Increased
274
15.90M
New
91
4.88M
Decreased
260
16.20M
Sold Out
81
2.68M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Drug Retailers
+0.86%
Food & Drug Retailing
+0.13%
Key Executives
Non-Executive Chairman/Independent Director
Gregory Kenny
Chief Executive Officer/Director
Michael Kaufmann
Chief Financial Officer
Jason Hollar
Corporate Executive
Victor Crawford
Corporate Executive
Stephen Mason
Chief Human Resource Officer
Ola Snow
Executive Vice President/Chief Information Officer
Brian Rice
Executive Vice President
Michele Holcomb
Chief Compliance Officer
Jessica Mayer
Independent Director
Carrie Cox
Independent Director
Bruce Downey
Independent Director
Sheri Edison
Independent Director
David Evans
Independent Director
Patricia Hemingway Hall
Independent Director
Akhil Johri
Independent Director
Nancy Killefer
Independent Director
Dean Scarborough
Independent Director
John Weiland
No Data
No Data
About CAH
Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; provides pharmacy management services to hospitals; and repackages generic pharmaceuticals and over-the-counter healthcare products. The Medical segment manufactures, sources and distributes a range of medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. This segment also distributes a range of national brand products and provides supply chain services and solutions to hospitals and other healthcare providers.

Webull offers kinds of Cardinal Health Inc stock information, including NYSE:CAH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CAH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CAH stock methods without spending real money on the virtual paper trading platform.